SENPLISYME, created in 2015 (United States), from 2757 sister brands and 17478 competing brands. SENPLISYME is owned by SANOFI, listed on the stock exchange of Paris Its International Securities Identification Number (ISIN) is FR0000120578. SENPLISYME belongs to the Drug Manufacturers business sector.